Efficacy of ribavirin against malignant glioma cell lines: Follow-up study

Ribavirin, a nucleic acid analog, has been employed as an antiviral agent against RNA and DNA viruses and has become the standard agent used for chronic hepatitis C in combination with interferon-α2a. Furthermore, the potential antitumor efficacy of ribavirin has attracted increasing interest. Recen...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncol Rep
Main Authors: Ochiai, Yushi, Sano, Emiko, Okamoto, Yutaka, Yoshimura, Sodai, Makita, Kotaro, Yamamuro, Shun, Ohta, Takashi, Ogino, Akiyoshi, Tadakuma, Hisashi, Ueda, Takuya, Nakayama, Tomohiro, Hara, Hiroyuki, Yoshino, Atsuo, Katayama, Yoichi
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2018
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5783620/
https://ncbi.nlm.nih.gov/pubmed/29251333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.6149
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki